# Midazolam Efficacy/Safety in Pre-Eclamptic C-Section Sedation

> **NCT07021521** · NA · COMPLETED · sponsor: **Zhuji People's Hospital of Zhejiang Province** · enrollment: 124 (actual)

## Conditions studied

- Midazolam
- Pre-eclampsia
- Cesarean Section
- Efficacy
- Safety

## Interventions

- **DRUG:** 0 mg/kg Midazolam (Control Group)
- **DRUG:** 0.01 mg/kg Midazolam Group
- **DRUG:** 0.02 mg/kg Midazolam Group
- **DRUG:** 0.03 mg/kg Midazolam Group

## Key facts

- **NCT ID:** NCT07021521
- **Lead sponsor:** Zhuji People's Hospital of Zhejiang Province
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-05
- **Primary completion:** 2023-04-03
- **Final completion:** 2023-04-26
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07021521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07021521, "Midazolam Efficacy/Safety in Pre-Eclamptic C-Section Sedation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07021521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*